BR112016017660A2 - - Google Patents

Info

Publication number
BR112016017660A2
BR112016017660A2 BR112016017660A BR112016017660A BR112016017660A2 BR 112016017660 A2 BR112016017660 A2 BR 112016017660A2 BR 112016017660 A BR112016017660 A BR 112016017660A BR 112016017660 A BR112016017660 A BR 112016017660A BR 112016017660 A2 BR112016017660 A2 BR 112016017660A2
Authority
BR
Brazil
Application number
BR112016017660A
Other languages
Portuguese (pt)
Other versions
BR112016017660B1 (pt
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50184787&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR112016017660(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BR112016017660A2 publication Critical patent/BR112016017660A2/pt
Publication of BR112016017660B1 publication Critical patent/BR112016017660B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/40—Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41—Glycosylation, sialylation, or fucosylation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR112016017660-0A 2014-02-27 2015-02-24 Método para a produção de uma glicoproteína recombinante BR112016017660B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14157030.9 2014-02-27
EP14157030 2014-02-27
PCT/EP2015/053804 WO2015128314A1 (en) 2014-02-27 2015-02-24 Modulation of cell growth and glycosylation in recombinant glycoprotein production

Publications (2)

Publication Number Publication Date
BR112016017660A2 true BR112016017660A2 (enExample) 2017-08-08
BR112016017660B1 BR112016017660B1 (pt) 2022-04-19

Family

ID=50184787

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016017660-0A BR112016017660B1 (pt) 2014-02-27 2015-02-24 Método para a produção de uma glicoproteína recombinante

Country Status (20)

Country Link
US (3) US20170058309A1 (enExample)
EP (1) EP3110961B1 (enExample)
JP (2) JP6831702B2 (enExample)
KR (1) KR102280638B1 (enExample)
CN (1) CN106133146B (enExample)
BR (1) BR112016017660B1 (enExample)
CA (1) CA2937611C (enExample)
DK (1) DK3110961T3 (enExample)
ES (1) ES2769003T3 (enExample)
HR (1) HRP20200100T1 (enExample)
HU (1) HUE047575T2 (enExample)
LT (1) LT3110961T (enExample)
MX (1) MX369395B (enExample)
PL (1) PL3110961T3 (enExample)
PT (1) PT3110961T (enExample)
RS (1) RS59881B1 (enExample)
RU (1) RU2712562C2 (enExample)
SG (1) SG11201606856SA (enExample)
SI (1) SI3110961T1 (enExample)
WO (1) WO2015128314A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX375714B (es) 2011-11-21 2025-03-06 Innovation Hammer Llc Métodos y sistemas para desarrollar plantas usando sustratos basados en silicato, cultivo de productividad fotosintética mejorada y fotoprotección mediante la utilización de glicopiranósidos exógenos para derivados de glicopiranosil-proteína endógenos, y formualaciones, procesos y sistemas para los mismos.
PT3110961T (pt) * 2014-02-27 2020-01-29 Hoffmann La Roche Modulação do crescimento celular e da glicosilação na produção de glicoproteínas recombinantes
EA202091598A3 (ru) * 2014-12-01 2021-01-29 Эмджен Инк. Процесс контроля уровня содержания гликанов в составе
CN109414027A (zh) * 2016-04-29 2019-03-01 创新汉玛有限责任公司 用聚糖复合物制剂处理光合生物和增加品质和产量的制剂和方法
WO2019077628A1 (en) * 2017-10-16 2019-04-25 Council Of Scientific & Industrial Research ZINC SUPPLEMENTATION TO DECREASE GALACTOSYLATION OF RECOMBINANT GLYCOPROTEINS
CA3094076C (en) * 2018-03-16 2025-11-25 Genzyme Corp Methods for improving cell viability in a production bioreactor
EP3775251A1 (en) 2018-03-26 2021-02-17 Amgen Inc. Total afucosylated glycoforms of antibodies produced in cell culture
US20210147532A1 (en) * 2018-05-24 2021-05-20 Ares Trading S.A. Method for controlling the afucosylation level of a glycoprotein composition
HU231514B1 (hu) 2018-11-07 2024-07-28 Richter Gedeon Nyrt. Sejttenyészetben előállított rekombináns glikoprotein glikozilációs mintázatának megváltoztatására szolgáló módszer
EP3880824B1 (en) * 2018-11-13 2024-07-24 Janssen Biotech, Inc. Control of trace metals during production of anti-cd38 antibodies
JP2020188737A (ja) * 2019-05-23 2020-11-26 東ソー株式会社 抗体依存性細胞傷害活性が向上した抗体の製造方法
US20230265204A1 (en) * 2020-04-24 2023-08-24 Hoffmann-La Roche Inc. Enzyme and pathway modulation with sulfhydryl compounds and their derivatives
WO2025036924A1 (en) * 2023-08-16 2025-02-20 Glaxosmithkline Intellectual Property Limited Method of controlling antibody glycosylation profile

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4767704A (en) 1983-10-07 1988-08-30 Columbia University In The City Of New York Protein-free culture medium
IL87737A (en) 1987-09-11 1993-08-18 Genentech Inc Method for culturing polypeptide factor dependent vertebrate recombinant cells
US5705364A (en) * 1995-06-06 1998-01-06 Genentech, Inc. Mammalian cell culture process
US6030945A (en) 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
EP0953041A4 (en) 1996-08-30 2003-01-29 Life Technologies Inc SERUM-FREE CULTURAL MEDIUM FOR MAMMAL CELLS AND THEIR USE
ATE314485T1 (de) * 1998-05-29 2006-01-15 Genentech Inc Zellkulturverfahren für die produktion von glycoproteinen
JP2001120262A (ja) * 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
EP1360314B1 (en) 2001-02-15 2009-01-14 Centocor, Inc. Chemically defined medium for cultured mammalian cells
US20050287666A1 (en) * 2004-06-29 2005-12-29 Invitrogen Corporation Cell culture medium comprising transition metals or trace elements
TWI384069B (zh) 2004-08-27 2013-02-01 Pfizer Ireland Pharmaceuticals 多胜肽之製法
DE602005026548D1 (de) * 2004-11-02 2011-04-07 Ares Trading Sa Serumfreies kulturmedium für säugerzellen
US20070231895A1 (en) 2005-11-02 2007-10-04 Lee Gene W Methods for adapting mammalian cells
AU2006324163B2 (en) 2005-12-08 2013-05-02 Amgen Inc. Improved production of glycoproteins using manganese
DK2041270T3 (da) * 2006-07-13 2014-01-27 Wyeth Llc Fremstilling af glycoproteiner
EP2064315B1 (en) 2006-11-03 2015-05-13 Wyeth LLC Glycolysis-inhibiting substances in cell culture
US9012180B2 (en) 2007-03-02 2015-04-21 Wyeth Llc Use of copper and glutamate in cell culture for production of polypeptides
WO2011019622A1 (en) 2009-08-14 2011-02-17 Genentech, Inc. Cell culture methods to make antibodies with enhanced adcc function
US20120309056A1 (en) * 2010-02-04 2012-12-06 Leon Arnaud Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
LT3330370T (lt) 2010-04-26 2021-06-10 Novartis Ag Cho ląstelių auginimo būdas
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
WO2012147048A2 (en) 2011-04-29 2012-11-01 Biocon Research Limited Methods for reducing accumulation of lactate during culturing and method for producing polypeptide
WO2013114245A1 (en) * 2012-01-30 2013-08-08 Dr. Reddy's Laboratories Limited Process of modulating man5 and/or afucosylation content of glycoprotein composition
US9598667B2 (en) 2013-10-04 2017-03-21 Abbvie Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
PT3110961T (pt) * 2014-02-27 2020-01-29 Hoffmann La Roche Modulação do crescimento celular e da glicosilação na produção de glicoproteínas recombinantes

Also Published As

Publication number Publication date
RU2016138176A (ru) 2018-03-29
RS59881B1 (sr) 2020-03-31
CN106133146A (zh) 2016-11-16
SI3110961T1 (sl) 2020-03-31
JP6934507B2 (ja) 2021-09-15
JP2017506515A (ja) 2017-03-09
EP3110961A1 (en) 2017-01-04
HRP20200100T1 (hr) 2020-04-03
CN106133146B (zh) 2021-05-04
CA2937611C (en) 2023-01-03
SG11201606856SA (en) 2016-09-29
RU2016138176A3 (enExample) 2018-10-29
US20240327890A1 (en) 2024-10-03
KR20160125514A (ko) 2016-10-31
US20170058309A1 (en) 2017-03-02
DK3110961T3 (da) 2020-02-03
WO2015128314A1 (en) 2015-09-03
PT3110961T (pt) 2020-01-29
MX369395B (es) 2019-11-07
ES2769003T3 (es) 2020-06-24
CA2937611A1 (en) 2015-09-03
HUE047575T2 (hu) 2020-04-28
EP3110961B1 (en) 2019-11-27
PL3110961T3 (pl) 2020-04-30
US20210222220A1 (en) 2021-07-22
MX2016010236A (es) 2016-10-13
KR102280638B1 (ko) 2021-07-22
JP6831702B2 (ja) 2021-02-17
RU2712562C2 (ru) 2020-01-29
LT3110961T (lt) 2020-02-10
BR112016017660B1 (pt) 2022-04-19
JP2020054351A (ja) 2020-04-09

Similar Documents

Publication Publication Date Title
BR112016018406A2 (enExample)
BR112016013482A2 (enExample)
BR112016018895A2 (enExample)
BR112016016195A2 (enExample)
BR112016013563A2 (enExample)
BR112016016225A2 (enExample)
BR112016016602A2 (enExample)
BR112016017303A2 (enExample)
BR112016018070A2 (enExample)
BR112016017913A2 (enExample)
BR112016018868A2 (enExample)
BR112016017950A2 (enExample)
BR112016013151A2 (enExample)
BR112016016106A2 (enExample)
BR112016012568A2 (enExample)
BR112016017262A2 (enExample)
BR112016017713A2 (enExample)
BR112016018578A2 (enExample)
BR112016016298A2 (enExample)
BR112016015645A2 (enExample)
BR112015029172A2 (enExample)
BR112016004754A2 (enExample)
BR112016012283A2 (enExample)
BR112016016389A2 (enExample)
BR112016017356A2 (enExample)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B09X Republication of the decision to grant [chapter 9.1.3 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 24/02/2015, OBSERVADAS AS CONDICOES LEGAIS.